Pituitary stalk interruption syndrome broadens the clinical spectrum of the TTC26 ciliopathy.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
09 2020
Historique:
received: 05 04 2020
revised: 27 06 2020
accepted: 27 06 2020
pubmed: 4 7 2020
medline: 13 7 2021
entrez: 4 7 2020
Statut: ppublish

Résumé

Ciliopathies are a heterogeneous group of disorders, related to abnormal ciliary function. Severe biliary ciliopathy, caused by bi-allelic mutations in TTC26, has been recently described in the context of a syndrome of polydactyly and severe neonatal cholestasis, with brain, kidney and heart involvement. Pituitary involvement has not been previously reported for patients with this condition. Pituitary stalk interruption syndrome (PSIS) is a congenital anomaly of the pituitary gland, diagnosed by characteristic MRI findings. We now describe four patients with TTC26 ciliopathy due to a homozygous c.695A>G p.Asn232Ser mutation and delineate PSIS as a novel clinical feature of this disorder, highlighting an important role of TTC26 in pituitary development.

Identifiants

pubmed: 32617964
doi: 10.1111/cge.13805
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

303-307

Informations de copyright

© 2020 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.

Références

Reiter JF, Leroux MR. Genes and molecular pathways underpinning ciliopathies. Nat Rev Mol Cell Biol. 2017;18(9):533-547.
Pedersen LB, Rosenbaum JL. Intraflagellar transport (IFT) role in ciliary assembly, resorption and signalling. Curr Top Dev Biol. 2008;85:23-61.
Waters AM, Beales PL. Ciliopathies: an expanding disease spectrum. Pediatr Nephrol. 2011;26(7):1039-1056.
Shaheen R, Szymanska K, Basu B, et al. Characterizing the morbid genome of ciliopathies. Genome Biol. 2016;17(1):242.
Shaheen R, Alsahli S, Ewida N, et al. Biallelic mutations in TTC26 (IFT56) cause severe biliary ciliopathy in humans. Hepatology. 2020;71(6):2067-2079.
Ishikawa H, Ide T, Yagi T, et al. TTC26/DYF13 is an intraflagellar transport protein required for transport of motility-related proteins into flagella. Elife. 2014;3:e01566.
Zhang Q, Liu Q, Austin C, Drummond I, Pierce EA. Knockdown of ttc26 disrupts ciliogenesis of the photoreceptor cells and the pronephros in zebrafish. Mol Biol Cell. 2012;23(16):3069-3078.
Tatsi C, Sertedaki A, Voutetakis A, et al. Pituitary stalk interruption syndrome and isolated pituitary hypoplasia may be caused by mutations in holoprosencephaly-related genes. J Clin Endocrinol Metab. 2013;98(4):E779-E784.
Ming JE, Muenke M. Holoprosencephaly: from Homer to Hedgehog. Clin Genet. 1998;53(3):155-163.
Wang Y, Martin JF, Bai CB. Direct and indirect requirements of Shh/Gli signaling in early pituitary development. Dev Biol. 2010;348(2):199-209.
Dubourg C, Lazaro L, Pasquier L, et al. Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients with features of holoprosencephaly spectrum: mutation review and genotype-phenotype correlations. Hum Mutat. 2004;24(1):43-51.
Bashamboo A, Bignon-Topalovic J, Rouba H, McElreavey K, Brauner R. A nonsense mutation in the hedgehog receptor CDON associated with pituitary stalk interruption syndrome. J Clin Endocrinol Metab. 2016;101(1):12-15.
Franca MM, Jorge AA, Carvalho LR, et al. Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ectopic posterior pituitary lobe without holoprosencephaly. J Clin Endocrinol Metab. 2010;95(11):E384-E391.
Zwaveling-Soonawala N, Alders M, Jongejan A, et al. Clues for polygenic inheritance of pituitary stalk interruption syndrome from exome sequencing in 20 patients. J Clin Endocrinol Metab. 2018;103(2):415-428.
Lucas-Herald AK, Kinning E, Iida A, et al. A case of functional growth hormone deficiency and early growth retardation in a child with IFT172 mutations. J Clin Endocrinol Metab. 2015;100(4):1221-1224.
Hietamaki J, Gregory LC, Ayoub S, et al. Loss-of-function variants in TBC1D32 underlie syndromic hypopituitarism. J Clin Endocrinol Metab. 2020;105(6):dgaa078.
Davis SW, Ellsworth BS, Perez Millan MI, et al. Pituitary gland development and disease: from stem cell to hormone production. Curr Top Dev Biol. 2013;106:1-47.
Sturm V, Leiba H, Menke MN, et al. Ophthalmological findings in Joubert syndrome. Eye (Lond). 2010;24(2):222-225.
Cavodeassi F, Creuzet S, Etchevers HC. The hedgehog pathway and ocular developmental anomalies. Hum Genet. 2019;138(8-9):917-936.
Markus B, Alshafee I, Birk OS. Deciphering the fine-structure of tribal admixture in the Bedouin population using genomic data. Heredity (Edinb). 2014;112(2):182-189.
Szymanska K, Berry I, Logan CV, et al. Founder mutations and genotype-phenotype correlations in Meckel-Gruber syndrome and associated ciliopathies. Cilia. 2012;1(1):18.
Zaki MS, Sattar S, Massoudi RA, Gleeson JG. Co-occurrence of distinct ciliopathy diseases in single families suggests genetic modifiers. Am J Med Genet A. 2011;155A(12):3042-3049.
Ben-Omran T, Alsulaiman R, Kamel H, Shaheen R, Alkuraya FS. Intrafamilial clinical heterogeneity of CSPP1-related ciliopathy. Am J Med Genet A. 2015;167A(10):2478-2480.

Auteurs

Odeya David (O)

Pediatric Endocrinology Unit, Soroka University Medical Center, Beer-Sheva, Israel.
Saban Pediatric Medical Center for Israel, Soroka University Medical Center, Beer-Sheva, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Marina Eskin-Schwartz (M)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Genetics Institute at Soroka University Medical Center and the Morris Kahn Laboratory of Human Genetics, National Center for Rare Diseases, at the Faculty of Health Sciences and National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Galina Ling (G)

Saban Pediatric Medical Center for Israel, Soroka University Medical Center, Beer-Sheva, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Pediatric Gastroenterology Unit, Soroka University Medical Center, Beer-Sheva, Israel.

Vadim Dolgin (V)

Genetics Institute at Soroka University Medical Center and the Morris Kahn Laboratory of Human Genetics, National Center for Rare Diseases, at the Faculty of Health Sciences and National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Eyal Kristal (E)

Saban Pediatric Medical Center for Israel, Soroka University Medical Center, Beer-Sheva, Israel.

Ela Benkowitz (E)

Radiology Department, Soroka Medical Center, Beer-Sheva, Israel.

Lidia Osyntsov (L)

Institute of Pathology, Soroka Medical Center, Beer-Sheva, Israel.

Libe Gradstein (L)

Genetics Institute at Soroka University Medical Center and the Morris Kahn Laboratory of Human Genetics, National Center for Rare Diseases, at the Faculty of Health Sciences and National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Ophthalmology Clinic, Southern District, Clalit Health Services, Beer-sheva, Israel.

Ohad S Birk (OS)

Genetics Institute at Soroka University Medical Center and the Morris Kahn Laboratory of Human Genetics, National Center for Rare Diseases, at the Faculty of Health Sciences and National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Neta Loewenthal (N)

Pediatric Endocrinology Unit, Soroka University Medical Center, Beer-Sheva, Israel.
Saban Pediatric Medical Center for Israel, Soroka University Medical Center, Beer-Sheva, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Baruch Yerushalmi (B)

Saban Pediatric Medical Center for Israel, Soroka University Medical Center, Beer-Sheva, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Pediatric Gastroenterology Unit, Soroka University Medical Center, Beer-Sheva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH